Research Advances in Traditional Chinese Medicine Treatment for Ischemic Stroke via Regulation of Programmed Cell Death

Authors

  • Litian Liu Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
  • Liyi Chi The 986th Hospital of Air Force Medical University, Xi’an, Shaanxi, 710032, China

DOI:

https://doi.org/10.53469/jcmp.2025.07(09).52

Keywords:

Ischemic stroke, Programmed death, Chinese medicine monomer, Compound Chinese Medicines

Abstract

Ischemic stroke (IS) is an acute cerebrovascular event caused by cerebral vascular occlusion, leading to cerebral tissue ischaemia and hypoxia, which in turn triggers neuronal cell death and corresponding neurological deficits. Multiple forms of programmed cell death contribute to its pathological progression. Traditional Chinese medicine exerts effects through multiple pathways, targets, and levels. In recent years, an increasing number of studies have demonstrated that traditional Chinese medicine can improve stroke outcomes by regulating programmed cell death. This paper reviews relevant research with the aim of providing new insights and directions for the prevention and treatment of IS using traditional Chinese medicine.

Downloads

Published

2025-09-27

How to Cite

Liu, L., & Chi, L. (2025). Research Advances in Traditional Chinese Medicine Treatment for Ischemic Stroke via Regulation of Programmed Cell Death. Journal of Contemporary Medical Practice, 7(9), 284–287. https://doi.org/10.53469/jcmp.2025.07(09).52

Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /www/bryanhousepub/ojs/plugins/generic/citations/CitationsPlugin.inc.php on line 49